Sipuleucel-T (Provenge) - Coverage Criteria for Prostate Cancer Clarification
National · Effective Oct 2, 2025
1 active Medicare policy lists Q2043, and 19 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Oct 2, 2025
19 policies from 17 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Personalized Vaccines (e.g., Provenge) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Personalized Vaccines (e.g., Provenge) | Not recorded | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Personalized Vaccines (e.g., Provenge) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Personalized Vaccines (e.g., Provenge) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Sipuleucel-T (e.g., Provenge) for the Treatment of Prostate Cancer | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| AIM MEDICAL POLICY - SIPULEUCEL-T: PROVENGE (Q2043) (RETIRED AS OF 02/02/2023) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Sipuleucel-T (Provenge) | Oct 9, 2010 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Sipuleucel-T (Provenge); CP.PHAR.120 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Q3 - 2026 Jefferson Health Plans MedOnc Master Drug List | Not recorded | Prior auth required |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Sipuleucel-T (Provenge) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| 00264 sipuleucel-T (Provenge) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Provenge | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Provenge (sipuleucel-T) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of Q2043 |
|---|---|---|
| Provenge (sipuleucel-T) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |